Identification and immunogenicity of Mannheimia haemolytica S1 outer membrane lipoprotein PlpF

Vaccine

Volumn 29, Issue 47, 2011, Pages 8712-8718

  Ayalew, Sahlu ^a   Shrestha, Binu ^a   Montelongo, Marie ^a   Wilson, Amanda E ^a   Confer, Anthony W ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Antibody; Bacteriolysis; Cattle; Complement mediated; Mannheimia haemolytica; Outer membrane protein; PlpF

Indexed keywords

BACTERIUM ANTIBODY; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; PASTEURELLA LIPOPROTEIN F; RECOMBINANT PASTEURELLA LIPOPROTEIN F; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOLYSIS; CALF (BOVINE); CARBOXY TERMINAL SEQUENCE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; IMMUNOGENICITY; MANNHEIMIA HAEMOLYTICA; MOUSE; NONHUMAN; PASTEURELLOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SEROTYPE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; CATTLE; CATTLE DISEASES; CLONING, MOLECULAR; COMPLEMENT SYSTEM PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION; LIPOPROTEINS; MANNHEIMIA HAEMOLYTICA; MICE; MICE, INBRED BALB C; PASTEURELLACEAE INFECTIONS; VACCINES, SYNTHETIC;

EID: 82455219305     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.074     Document Type: Article

References (37)

1. Panciera R.J., Confer A.W. Pathogenesis and pathology of bovine pneumonia. Vet Clin North Am Food Anim Pract 2010 Jul, 26(July (2)):191-214.
2. Confer A.W. Update on bacterial pathogenesis in BRD. Anim Health Res Rev 2009, 10(December (2)):145-148.
3. Shewen P.E., Wilkie B.N. Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Can J Vet Res 1988, 52(January (1)):30-36.
4. Confer A.W., McCraw R.D., Durham J.A., Morton R.J., Panciera R.J. Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1. Vet Immunol Immunopathol 1995, 47(July (1-2)):101-110.
5. Morton R.J., Panciera R.J., Fulton R.W., Frank G.H., Ewing S.A., Homer J.T., et al. Vaccination of cattle with outer membrane protein-enriched fractions of Pasteurella haemolytica and resistance against experimental challenge exposure. Am J Vet Res 1995, 56(July (7)):875-879.
6. Mosier D.A., Simons K.R., Confer A.W., Panciera R.J., Clinkenbeard K.D. Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis. Infect Immun 1989, 57(March (3)):711-716.
7. Pandher K., Confer A.W., Murphy G.L. Genetic and immunologic analyses of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica serotype 1. Infect Immun 1998, 66(December (12)):5613-5619.
8. Pandher K., Murphy G.L., Confer A.W. Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1. Vet Microbiol 1999, 65(March (3)):215-226.
9. Ayalew S., Confer A.W., Hartson S.D., Shrestha B. Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates. Proteomics 2010, 10(June (11)):2151-2164.
10. Cooney B.J., Lo R.Y. Three contiguous lipoprotein genes in Pasteurella haemolytica A1 which are homologous to a lipoprotein gene in Haemophilus influenzae type b. Infect Immun 1993, 61(November (11)):4682-4688.
11. Murphy G.L., Whitworth L.C. Analysis of tandem, multiple genes encoding 30-kDa membrane proteins in Pasteurella haemolytica A1. Gene 1993, 129(July (1)):107-111.
12. Nardini P.M., Mellors A., Lo R.Y. Characterization of a fourth lipoprotein from Pasteurella haemolytica A1 and its homology to the OmpA family of outer membrane proteins. FEMS Microbiol Lett 1998, 165(August (1)):71-77.
13. Ayalew S., Confer A.W., Blackwood E.R. Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE. Infect Immun 2004, 72(December (12)):7265-7274.
14. Ayalew S., Confer A.W., Payton M.E., Garrels K.D., Shrestha B., Ingram K.R., et al. Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin. Vaccine 2008, 26(September (38)):4955-4961.
15. Confer A.W., Ayalew S., Montelongo M., Step D.L., Wray J.H., Hansen R.D., et al. Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein. Vaccine 2009, 27(March (11)):1771-1776.
16. Highlander S.K. Molecular genetic analysis of virulence in Mannheimia (pasteurella) haemolytica. Front Biosci 2001, 6(September):D1128-D1150.
17. Madico G., Welsch J.A., Lewis L.A., McNaughton A., Perlman D.H., Costello C.E., et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 2006, 177(July (1)):501-510.
18. Murphy G.L., Whitworth L.C., Clinkenbeard K.D., Clinkenbeard P.A. Hemolytic activity of the Pasteurella haemolytica leukotoxin. Infect Immun 1995, 63(August (8)):3209-3212.
19. Ayalew S., Blackwood E.R., Confer A.W. Sequence diversity of the immunogenic outer membrane lipoprotein PlpE from Mannheimia haemolytica serotypes 1, 2, and 6. Vet Microbiol 2006, 114(May (3-4)):260-268.
20. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., et al. Short protocols in molecular biology 1999, John Wiley & Sons, Inc., New York.
21. Confer A.W., Clinkenbeard K.D., Gatewood D.M., Driskel B.A., Montelongo M. Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin. Vaccine 1997, 15(August-September (12-13)):1423-1429.
22. Confer A.W., Ayalew S., Step D.L., Trojan B., Montelongo M. Intranasal vaccination of young Holstein calves with Mannheimia haemolytica chimeric protein PlpE-LKT (SAC89) and cholera toxin. Vet Immunol Immunopathol 2009, 132(December (2-4)):232-236.
23. Frey A., Di Canzio J., Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998, 221(December (1-2)):35-41.
24. Chae C.H., Gentry M.J., Confer A.W., Anderson G.A. Resistance to host immune defense mechanisms afforded by capsular material of Pasteurella haemolytica, serotype 1. Vet Microbiol 1990, 25(November (2-3)):241-251.
25. Confer A.W., Ayalew S., Panciera R.J., Montelongo M., Whitworth L.C., Hammer J.D. Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine. Vaccine 2003, 21(June (21-22)):2821-2829.
26. Petrie A., Watson P. Statistics for veterinary and animal science 1999, Blackwell Science, Ltd., Oxford. 1st ed.
27. Step D.L., Confer A.W., Kirkpatrick J.G., Richards J.B., Fulton R.W. Respiratory tract infections in dairy calves from birth to breeding age: detection by laboratory isolations and seroconversions. Bovine Pract 2005, 39:44-53.
28. Prado M.E., Prado T.M., Payton M., Confer A.W. Maternally and naturally acquired antibodies to Mannheimia haemolytica and Pasteurella multocida in beef calves. Vet Immunol Immunopathol 2006, 111(June (3-4)):301-307.
29. Pizza M., Donnelly J., Rappuoli R. Factor H-binding protein, a unique meningococcal vaccine antigen. Vaccine 2008, 26(December (Suppl. 8)):146-148.
30. Cantini F., Savino S., Scarselli M., Masignani V., Pizza M., Romagnoli G., et al. Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis. J Biol Chem 2006, 281(March (11)):7220-7227.
31. Hou V.C., Koeberling O., Welsch J.A., Granoff D.M. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870. J Infect Dis 2005, 192(August (4)):580-590.
32. Masignani V., Comanducci M., Giuliani M.M., Bambini S., Adu-Bobie J., Arico B., et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 2003, 197(March (6)):789-799.
33. Confer A.W., Ayalew S., Panciera R.J., Montelongo M., Wray J.H. Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge. Vaccine 2006, 24(March (13)):2248-2255.
34. Parker J.M., Guo D., Hodges R.S. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986, 25(September (19)):5425-5432.
35. Lawrence P.K., Kittichotirat W., Bumgarner R.E., McDermott J.E., Herndon D.R., Knowles D.P., et al. Genome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolates. J Bacteriol 2010, 192(February (4)):1167-1168.
36. Koeberling O., Welsch J.A., Granoff D.M. Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870. Vaccine 2007, 25(February (10)):1912-1920.
37. Singh K., Ritchey J.W., Confer A.W. Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia. Vet Pathol 2011, 48(March (2)):338-348.